Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human FOXO1A ELISA Kit (AC2749)
Cat.#: ASET-1338
Specifications
Description Human FOXO1A ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human FOXO1A concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.024 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1655 Rat GDNF ELISA Kit (AC3066) Quantitative inquiry ASET-1111 Human HAGH ELISA Kit (AC2522) Quantitative inquiry ASET-2201 Rat LC3B ELISA Kit (AC3612) Quantitative inquiry ASET-2516 Mouse alpha B Crystallin ELISA Kit (AC3927) Quantitative inquiry ASET-2159 Human HAAO ELISA Kit (AC3570) Quantitative inquiry ASET-1609 Rat NRG2 ELISA Kit (AC3020) Quantitative inquiry ASET-1568 Human GPCR GPR35 ELISA Kit (AC2979) Quantitative inquiry ASET-1463 Human Ornithine Aminotransferase ELISA Kit (AC2874) Quantitative inquiry ASET-2449 Human TPH2 ELISA Kit (AC3860) Quantitative inquiry ASET-1707 Porcine Obestatin ELISA Kit (AC3118) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket